THC Biomed Intl Ltd.
THC
CNSX
| 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -690.50K | -736.00K | -249.10K | -1.10M | -103.50K |
| Total Depreciation and Amortization | 141.70K | 158.20K | 159.50K | 310.30K | 58.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 90.50K | 235.90K | 78.20K | 425.00K | -299.60K |
| Change in Net Operating Assets | 487.00K | 314.20K | -163.90K | 151.60K | -39.00K |
| Cash from Operations | 28.70K | -27.70K | -175.30K | -211.20K | -383.30K |
| Capital Expenditure | -300.00 | -52.80K | -300.00 | -124.60K | -124.70K |
| Sale of Property, Plant, and Equipment | -- | 2.50K | -- | 149.20K | 2.16M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -58.90K | -47.50K | 17.60K | -73.00K | -- |
| Cash from Investing | -59.20K | -97.80K | 17.30K | -48.40K | 2.03M |
| Total Debt Issued | 248.10K | 201.30K | -- | 976.50K | 102.10K |
| Total Debt Repaid | -96.20K | -105.90K | -105.60K | -1.31M | -1.42M |
| Issuance of Common Stock | -- | -- | -- | 0.00 | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 112.10K | 70.70K | -79.40K | -262.00K | -1.04M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 81.70K | -54.70K | -237.40K | -521.50K | 614.10K |